Tuesday, September 18, 2018

√ Weekend Reads: Stem Cells, Organoids, Cancer, Crispr A Tiger Named Igor

 as stem cells for Igor are part of recommended weekend reads √ Weekend reads: stem cells, organoids, cancer, CRISPR  a tiger named Igor
A tiger in an open source image (not Igor) as stem cells for Igor are part of recommended weekend reads

What are your typical weekend reads? If you are a scientist, they might often include a great deal of science. I always hope I can find time for reading for pleasure too, but about as close as I get to that is the New York Times on Sunday.


Here are some recommended science reads for this weekend including approachable media articles on interesting developments.


Blood test shows promise for spotting early cancers. In addition to being a cancer researcher, as a cancer survivor myself and someone interested in blood tests from prostate and other cancers, I found this encouraging and interesting.


Igor the Siberian tiger gets stem-cell hip treatment in Hungary (some hype here or overexuberance?)


This company is making an at-home CRISPR kit to find out what’s making you sick


Ethics of human brain research including organoids. This commentary comes from Nita Farahany and Hank Greely and colleagues. This topic seems even more important as we enter the age of vascularized organoids, including the two new papers below:



“There’s a dilema with stem cell therapy in Florida.” An investigative report from WPTV in Florida, which focuses on allegations regarding the Lung Institute and other issues with stem cell clinics in that state.


Scientists generate an atlas of the human genome using stem cells


“‘Incompatible’ donor stem cells cure 4dukt sickle cell patients” A cure means forever so is this headline too much?


 New Company, MAGiQ, Aims to Develop Stem Cell Therapies for ALS and Like Diseases (In an kala when we are trying to avoid hype, I’m not sure about the wisdom of the name of this company.)



Sumber aciknadzirah.blogspot.com